HANTZ FINANCIAL SERVICES, INC.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1071061
SOUTHFIELD, MI
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$278,722
-$63,557 QoQ
Shares Held
447
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#959
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $21,275,017 across 57 Biotechnology names. REGN ranks #14 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,883 | $4,781,259 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
58,496 | $4,578,481 | |
| 3 | ARGX |
Argenx SE
|
2,816 | $2,612,600 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
34,865 | $1,233,872 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
3,961 | $954,482 | |
| 6 | EXEL |
Exelixis, Inc.
|
16,074 | $874,586 | |
| 7 | CYTK |
Cytokinetics Inc
|
10,063 | $857,266 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
11,424 | $653,681 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $278,722 | 447 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $342,279 | 443 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $209,176 | 271 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $100,084 | 178 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $56,700 | 108 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $40,590 | 64 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $52,000 | 73 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $76,740 | 73 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $40,990 | 39 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $32,724 | 34 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $29,861 | 34 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $27,980 | 34 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $40,956 | 57 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $73,950 | 90 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $64,934 | 90 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $83,353 | 121 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $78,620 | 133 | Shares | Sole | 2024-08-06 | |
| 2022-03-31 | $113,842 | 163 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $221,663 | 351 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $128,298 | 212 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $120,086 | 215 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $141,468 | 299 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $12,203,358 | 25,260 | Shares | Sole | 2024-08-06 | |
| 2020-09-30 | $13,705,093 | 24,483 | Shares | Sole | 2024-08-06 | |
| 2020-06-30 | $14,560,356 | 23,347 | Shares | Sole | 2024-08-06 | |
| 2020-03-31 | $10,850,780 | 22,222 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||